This suggests that other mononuclear cells from diabetic patients, such as monocytes and/or CD8+ lymphocytes and/or NK cells, should be more activated to help control toxoplasmosis via the production of this pro-inflammatory cytokine. The gene discussed is CD8A; the disease is toxoplasmosis.